• Profile

AAD: Two new psoriasis guidelines address comorbidities, biologic treatment

Newswise Feb 15, 2019

To help physicians treat the millions of people affected by psoriasis and improve their quality of life, the American Academy of Dermatology (AAD) and the National Psoriasis Foundation (NPF) have released two new guidelines outlining best practices for managing the inflammatory skin disease.

The symptoms of psoriasis are visible on the skin, but the effects of the condition extend beyond what meets the eye. The disease is associated with several other physical and mental conditions, and it can have a significant impact on patients’ quality of life.

Published online in the Journal of the American Academy of Dermatology on February 13, the guidelines were developed by an expert work group composed of several dermatologists, as well as a cardiologist, a rheumatologist, and patient representatives.

“It is critical for both patients and doctors to understand the complexity of psoriasis. It is not just a skin disease; it is a serious condition that can affect all aspects of a patient’s health,” says Randy Beranek, president and CEO of the NPF. “Our goal in establishing these guidelines is to help health-care professionals educate their patients on the best way to treat their disease and mitigate the effects psoriasis can have on a patient’s overall health and well-being.”

Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities” focuses on the other health conditions that may be associated with the disease, including psoriatic arthritis, cardiovascular disease, metabolic syndrome, and inflammatory bowel disease. The guideline also addresses the increased risk of anxiety and depression in psoriasis patients, as well as the effects of smoking and alcohol consumption, which can increase one’s risk of developing the disease or make the condition worse in those who already have it.

“We believe this guideline will be a vital resource in the treatment of psoriasis,” says board-certified dermatologist Craig A. Elmets, MD, FAAD, co-chair of the work group that developed the guidelines. “Doctors should be aware of the conditions associated with this disease, educate patients accordingly, and work with those patients and other physicians to ensure that each patient receives the appropriate screening and treatment.”

Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics” provides an overview of the biologic medications available for the treatment of moderate to severe psoriasis. In addition to outlining the research on these drugs’ effectiveness and recommendations for their use, the guideline describes the potential adverse effects of each biologic.

“Before starting any psoriasis treatment, it’s important for patients to understand its potential effects, both positive and negative,” says board-certified dermatologist Alan Menter, MD, FAAD, co-chair of the guidelines work group. “This guideline provides physicians with the information they need to discuss biologic medications with their patients and help them choose the treatment plan that’s best for them.”

“If you’re struggling with psoriasis, a board-certified dermatologist can help you manage the condition and improve your quality of life,” adds board-certified dermatologist Suzanne M. Olbricht, MD, FAAD, president of the AAD. “We hope these guidelines serve as a valuable resource for physicians in providing high-quality care for psoriasis patients.”

The two guidelines published today are the first installments in a series of six, with four other psoriasis guidelines slated for publication in Journal of the American Academy of Dermatology in the coming months. Upcoming guidelines will address phototherapy, the treatment of pediatric patients, non-biologic systemic medications, and topical therapy.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free.
  • 55 lakhs+ doctors trust M3 globally

  • Nonloggedininfinity icon
    Unlimited access to original articles by experts
  • Nonloggedinlock icon
    Secure: we never sell your data
  • Signing up takes less than 2 mins
Try M3 India / Log In
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen